The Valley Desk

Clinical trial reportGastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer AssociationPublished

Q-TWiST analysis of first-line nivolumab plus chemotherapy versus chemotherapy in patients with advanced gastric cancer, gastroesophageal junction cancer, or esophageal adenocarcinoma from CheckMate 649: 4-year follow-up results

Read the publication ↗ Open access copy ↗

Regional connection

Verified Author affiliations on the Europe PMC record name Bristol Myers Squibb, Thomas Jefferson University Hospital, with Jefferson Health linked by the institution reference. Affiliation source

Publication record

Type
Clinical trial report
Venue
Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
Published
Subject terms
Esophagogastric Junction; Humans; Adenocarcinoma; Esophageal Neoplasms; Stomach Neoplasms; Antineoplastic Combined Chemotherapy Protocols; Survival Rate; Follow-Up Studies; Adult; Aged; Middle Aged; Female
PubMed ID
40632415
PubMed Central ID
PMC12378121
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal